Trials / Completed
CompletedNCT05006235
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Ahmed Noaman · Academic / Other
- Sex
- All
- Age
- 1 Hour – 6 Hours
- Healthy volunteers
- Not accepted
Summary
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn: Randomized controlled trial to assess:
Detailed description
This is a randomized double-blind randomized controlled trial. It had been conducted at the Neonatal Intensive Care Unit (NICU) of Mansoura University Children's Hospital, Egypt Written informed consent had been taken from all parents whose infants were recruited in the study. The ethics committee of the faculty of medicine has approved the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epinephrine Inhalation Solution | |
| DRUG | Salbutamol | |
| DRUG | Saline Inhalants |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-12-31
- Completion
- 2015-12-31
- First posted
- 2021-08-16
- Last updated
- 2021-08-16
Source: ClinicalTrials.gov record NCT05006235. Inclusion in this directory is not an endorsement.